Obituaries
PGe
PG Store
Archives
Classifieds
Classified
Events
Jobs
Real Estate
Legal Notices
Pets
MENU
SUBSCRIBE
LOGIN
REGISTER
LOG OUT
MY PROFILE
Home
News
Local
Sports
Opinion
A&E
Life
Business
Contact Us
NEWSLETTERS
MENU
ACCOUNT
Subscribe
Login
Register
Log out
My Profile
Subscriber Services
Search
SECTIONS
HOME
Homepage
This Just In
Chats
Weather
Traffic
Event Guide
PG Store
PGe
Video
Photos
The Digs
RSS Feeds
NEWS
News Home
COVID-19
World
Nation
State
Obituaries
News Obituaries
Politics
Education
Portfolio
Science
Health & Wellness
Environment
Aging Edge
Transportation
Faith & Religion
Crimes & Courts
Social Services
LOCAL
Local Home
Region
City
North
East
West
South
Washington
Westmoreland
The Neighborhood
Obituaries
Classifieds
Legal Notices
Real Estate
SPORTS
Sports Home
Steelers
Penguins
Pirates
Sports Columns
Gene Collier
Ron Cook
Joe Starkey
Paul Zeise
High School Sports
College Sports
Pitt
Penn State
WVU
NCAA
NFL
MLB
NBA
NHL
North Shore Drive Podcast
OPINION
Opinion Home
Editorials
Letters
Op-Ed Columns
PG Columnists
Insight
A&E
A&E Home
Celebrities
Movies
TV & Radio
Music
Concert Listings
Theatre & Dance
Art & Architecture
Books
Events
LIFE
Life Home
Food
Buying Here
Homes & Gardens
Style & Fashion
Travel
Restaurants
Seen
goodness
Random Acts of Kindness
Pets
Beer Me
Outdoors
Holidays
BUSINESS
Business Home
Your Money
Wheels
Workzone
Business Health
Tech News
Building PGH
Powersource
Business / Law
Top Workplaces
Business of Pittsburgh
Consumer Alerts
OTHER
PGe
NEWSLETTERS
PG STORE
ARCHIVES
CLASSIFIEDS
OBITUARIES
JOBS
LEGAL NOTICES
REAL ESTATE
CLASSIFIEDS
EVENTS
PETS
CONTACT US / FAQ
CONTACT US
ADVERTISING
CAREER OPPORTUNITIES
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Moderna, Inc. - Common Stock
(NQ:
MRNA
)
29.89
UNCHANGED
Streaming Delayed Price
Updated: 4:00 PM EST, Dec 16, 2025
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Moderna, Inc. - Common Stock
< Previous
1
2
...
28
29
30
31
32
33
34
35
36
...
99
100
Next >
Moderna, Regeneron Pharmaceuticals And 2 Other Stocks Insiders Are Selling
↗
July 15, 2024
Via
Benzinga
2 Growth Stocks Down 25% to Buy Right Now
↗
July 15, 2024
Discounted stock prices make these strong brands worth considering as investments.
Via
The Motley Fool
Is Moderna Stock a Buy?
↗
July 14, 2024
The biotech is proving that it's not a pandemic stock.
Via
The Motley Fool
Health Officials Keep Close Eye On Bird Flu As It Infects Cows For The First Time
↗
July 10, 2024
Avian influenza continues to spread among animals and has infected four dairy workers in the US. Concerns about human-to-human transmission are low.
Via
Benzinga
3 Pharma Stocks That Could Make Your Grandchildren Rich
↗
July 10, 2024
Investors might want to consider the top pharma stocks in the current environment as they are beating most others.
Via
InvestorPlace
Unpacking the Latest Options Trading Trends in Moderna
↗
July 08, 2024
Via
Benzinga
Unpacking the Latest Options Trading Trends in Moderna
↗
July 05, 2024
Via
Benzinga
Here's How Much $1000 Invested In Moderna 5 Years Ago Would Be Worth Today
↗
July 04, 2024
Via
Benzinga
Investor That Backed Moderna Raises $3.6B For AI-driven Biotech Ventures
↗
July 10, 2024
The funds are intended to launch a series of new biotech companies that will harness the power of generative artificial intelligence for drug discovery.
Via
Benzinga
Topics
Artificial Intelligence
Moderna to Report Second Quarter 2024 Financial Results on Thursday, August 1, 2024
July 10, 2024
Via
ACCESSWIRE
Moderna To Collaborate With Mitsubishi On Respiratory Vaccine Promotion In Japan
↗
July 09, 2024
Moderna and Mitsubishi signed a joint agreement regarding the co-promotion of Moderna's respiratory vaccine portfolio in Japan.
Via
Benzinga
Moderna And Mitsubishi Tanabe Pharma Corporation Enter Joint Agreement to Promote Moderna’s mRNA Respiratory Vaccine Portfolio in Japan, Including COVID-19 Vaccines
July 08, 2024
Via
ACCESSWIRE
3 Healthcare Stocks to Sell in July Before They Crash & Burn
↗
July 08, 2024
Many healthcare names are attractive. But drugstore chains and some drug makers have poor outlooks. Here are three healthcare stocks to sell.
Via
InvestorPlace
What's Going On With Moderna Stock Friday?
↗
June 28, 2024
Moderna's RSV vaccine, mRNA-1345, is designed to protect adults aged 60 and older from respiratory disease caused by the RSV infection.
Via
Benzinga
In-Depth Examination Of 10 Analyst Recommendations For Moderna
↗
June 27, 2024
Via
Benzinga
The 3 Best Gene Editing Stocks to Buy in July 2024
↗
July 08, 2024
Gene editing is revolutionizing medicine, creating substantial opportunities for some of the best gene editing stocks.
Via
InvestorPlace
3 Biotech Stocks to Sell in July Before They Crash & Burn
↗
July 05, 2024
While biotech stocks have potential to provide high returns, they are often overly dependent on drug approvals. Sell these before its too late
Via
InvestorPlace
3 Biotech Stocks Turning DNA Dreams Into Dollars
↗
July 05, 2024
Investors should consider buying into one of the future avenues of medicine by investing in these three BNA biotech stocks.
Via
InvestorPlace
AI Has 'The Hallmarks Of An Inflating Bubble,' Warns Veteran Wall Street Investor
↗
July 04, 2024
Word to the wise: Ed Yardeni, in a July 4 note, warns his clients: "Too much capital can end even the best of parties."
Via
Benzinga
Topics
Artificial Intelligence
What's Going On With Moderna Stock Wednesday
↗
July 03, 2024
Moderna announced a $176 million award for the development of an mRNA-based Influenza vaccine.
Via
Benzinga
mRNA Technology Promises To Make A Long-Time Coming Turning Point In Cancer Treatment
↗
July 02, 2024
The medical and pharmaceutical community continues to embrace emerging technologies, beginning with mRNA that rose to fame during the COVID-19 pandemic. The beauty of mRNA technology is that it opens...
Via
Benzinga
London High Court Ruling Fuels Pfizer And Moderna Legal Dispute Over COVID-19 Vaccine Patents
↗
July 02, 2024
Pfizer and Moderna continue their legal battle over COVID-19 vaccine patents following a mixed ruling by London's High Court, with potential appeals on the horizon and significant financial stakes...
Via
Benzinga
Topics
Intellectual Property
Biotech Stock Breakout: IBB Eyes Resistance with Amgen and Vertex
July 02, 2024
The biotech sector (IBB) is trading just 3% away from its 52-week high and a significant resistance level, suggesting a potential breakout.
Via
MarketBeat
Topics
ETFs
Amid Rapidly Rising Bird Flu Cases, Moderna Lands $176M Worth US Government Contract For Vaccine
↗
July 02, 2024
The funds will be utilized to finalize the late-stage development and testing of a pre-pandemic mRNA-based vaccine against H5N1 avian influenza.
Via
Benzinga
Moderna Receives Project Award through BARDA's Rapid Response Partnership Vehicle Consortium to Accelerate Development of mRNA-based Pandemic Influenza Vaccine
July 02, 2024
Via
ACCESSWIRE
Surprise! 3 Stocks That Are Outperforming Nvidia in 2024.
↗
July 01, 2024
There are more marketplace opportunities than just AI which is why these stocks that are outperforming Nvidia have done so well.
Via
InvestorPlace
Topics
Artificial Intelligence
Moderna And Walgreens Boots Alliance Were Among The 10 Biggest Large Cap Losers Last Week (June 23 - June 29): Are These In Your Portfolio?
↗
June 30, 2024
10 worst performing large-cap stocks last week: Walgreens, Floor & Decor, Moderna, Birkenstock, BeiGene, Pool Corp, JD.com, Ecopetrol, International Paper, Micron.
Via
Benzinga
Treasure Hunt: 3 Biotech Stocks Wall Street Hasn’t Discovered Yet
↗
June 28, 2024
Undiscovered biotech stocks can be risky but rewarding, especially when it involves mid-cap stocks with promise and no profit.
Via
InvestorPlace
EMA Committee For Medicinal Products For Human Use Adopts Positive Opinion Recommending Marketing Authorization Of Moderna’s RSV Vaccine, mRESVIA(R)
June 28, 2024
Via
ACCESSWIRE
Silver Prices Fell To A 6-Week Low
↗
June 27, 2024
Silver prices held below $29 an ounce, near a six-week low, and were pressured by a strong dollar and Treasury bond yields after hawkish remarks from a Federal Reserve official.
Via
Talk Markets
Topics
Bonds
Economy
< Previous
1
2
...
28
29
30
31
32
33
34
35
36
...
99
100
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
TOP
Email a Story
Your e-mail:
Friends e-mail:
Submit